Yi Su
Xin Zhang
Wei Deng- 1Department of Digestive Oncology, Beijing Chaoyang Integrative Medicine Rescue and First Aid Hospital, Beijing, China
- 2General Surgery Department, Friendship Hospital, Capital Medical University, Beijing, China
A Correction on
Immunotherapy in conversion therapy for gastric cancer: current status, progress, and challenges
By Su Y, Zhang X and Deng W (2025) Front. Oncol. 15:1637657. doi: 10.3389/fonc.2025.1637657
Author “Yi Su” was erroneously assigned as the corresponding author in the published article. The correct corresponding author is “Wei Deng”.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: gastric cancer, immunotherapy, conversion therapy, R0 resection rate, multimodal therapy
Citation: Su Y, Zhang X and Deng W (2025) Correction: Immunotherapy in conversion therapy for gastric cancer: current status, progress, and challenges. Front. Oncol. 15:1730862. doi: 10.3389/fonc.2025.1730862
Received: 23 October 2025; Accepted: 06 November 2025; Revised: 03 November 2025;
Published: 20 November 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Su, Zhang and Deng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Deng, ZGVuZ3dlaXdlaUAxMjYuY29t